Aimery deGramont (Aimery de Gramont)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Prognostic Factors

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

JNCI cancer spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Benoist Chibaudel, Morteza Raeisi, Romain Cohen, Greg Yothers, Richard M Goldberg, Jean-Baptiste Bachet, Norman Wolmark, Takayuki Yoshino, Hans-Joachim E Schmoll, Rachel Kerr, Sara Lonardi, Thomas J George, Einat Shacham-Shmueli, Qian Shi, Thierry André, Aimery deGramont
Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven R Alberts, Aimery deGramont, Jeffrey A Meyerhardt, Thomas J George, Hans-Joachim E Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A Sinicrope, Eiji Oki, Anthony Frank Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M Goldberg, Gilles Manceau, Demetris Papamichael
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Claire Gallois, Qian Shi, Levi D Pederson, Thierry André, Timothy J Iveson, Alberto F Sobrero, Steven R Alberts, Aimery deGramont, Jeffrey A Meyerhardt, Thomas J George, Hans-Joachim E Schmoll, Ioannis Souglakos, Andrea Harkin, Roberto Labianca, Frank A Sinicrope, Eiji Oki, Anthony Frank Shields, Ioannis Boukovinas, Rachel Kerr, Sara Lonardi, Greg Yothers, Takayuki Yoshino, Richard M Goldberg, Gilles Manceau, Demetris Papamichael
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Josep Tabernero, Takayuki Yoshino, Sebastian Stinzing, Aimery deGramont, Peter Gibbs, Derek J Jonker, Peter Nygren, Christos A Papadimitriou, Gerald W Prager, Roger Tell, Heinz-Josef Lenz
A Randomized Phase III Study of Arfolitixorin Versus Leucovorin with 5-Fluorouracil, Oxaliplatin and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial. Cancer research communications (2023)
Claire Gallois, Qian Shi, Jeffrey P Meyers, Timothy J Iveson, Steven R Alberts, Aimery deGramont, Alberto F Sobrero, Daniel G Haller, Eiji Oki, Anthony Frank Shields, Richard M Goldberg, Rachel Kerr, Sara Lonardi, Greg Yothers, Caroline Kelly, Ioannis Boukovinas, Roberto Labianca, Frank A Sinicrope, Ioannis Souglakos, Takayuki Yoshino, Jeffrey A Meyerhardt, Thierry André, Demetris Papamichael, Gilles Manceau
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Nadine Jackson McCleary, William S Harmsen, Ellana Haakenstad, James M Cleary, Jeffrey A Meyerhardt, Zalcberg John, Richard A Adams, Axel Grothey, Alberto F Sobrero, Eric Van Cutsem, Richard M Goldberg, Marc Peeters, Josep Tabernero, Matthew T Seymour, Leonard B Saltz, Bruce J Giantonio, Dirk Arnold, Mace L Rothenberg, Miriam Koopman, Hans-Joachim Schmoll, Henry C Pitot, Paulo M Hoff, Niall C Tebbutt, Gianluca Masi, John Souglakos, Carsten Bokemeyer, Volker Heinemann, Takayuki Yoshino, Benoist Chibaudel, Aimery deGramont, Qian Shi, Stuart M Lichtman
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials. JNCI cancer spectrum 6 (2) (2022)
Gilles Manceau, Valérie Taly, Julie Henriques, Camille Bourreau, Laurent Mineur, Jaafar Bennouna, Jérôme Desrame, Christophe Louvet, Céline Lepere, May Mabro, Joëlle Egreteau, Olivier Bouche, Claire Mulot, Katia Hormigos, Kariman Chaba, Thibault Mazard, Aimery deGramont, Dewi Vernerey, Thierry André, Pierre Laurent-Puig
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)